Seven Million and Waiting: The NHS Has Become a Monument to Everything Wrong With Central Planning

The Queue Nobody Wants to Talk About Honestly

As of early 2025, the NHS waiting list in England alone stands at approximately 7.5 million cases, representing a record backlog that no serious person can dismiss as a temporary post-pandemic blip. Patients are waiting months — sometimes years — for procedures that in comparable European nations, many of which operate mixed public-private systems, are completed within weeks. The human cost is immeasurable: conditions worsening during the wait, working lives disrupted, mental health deteriorating in the queue. The political cost, one would have hoped, might have forced a reckoning. Instead, what we have received from the current government is a restatement of faith in the very orthodoxy that produced this catastrophe.

Keir Starmer's administration came to office promising to "fix" the NHS. The method? Billions more in public funding, a new workforce plan, and a firm refusal to countenance any structural reform that might involve — heaven forbid — the private sector, patient choice, or market incentives. It is the political equivalent of a mechanic who, upon discovering a broken engine, resolves to fill it with more petrol.

The Bureaucracy Swallowing the Budget

Britain spends roughly £180 billion per year on the NHS, a figure that has grown in real terms almost every year since the service was founded. And yet, productivity — measured as output per unit of input — remains stubbornly below pre-pandemic levels. According to the Office for National Statistics, NHS productivity in 2023 was still around 10 to 12 per cent below its 2019 baseline. The money is not disappearing into thin air. It is disappearing into administration.

The NHS employs more managers and administrators than it does hospital beds. NHS England alone has accumulated layers of integrated care boards, sustainability and transformation partnerships, and strategic commissioning bodies, each with their own leadership structures, consultancy contracts, and communications teams. A 2023 report from the Institute for Fiscal Studies noted that administrative costs within the NHS have grown faster than frontline clinical spending in several recent budget cycles. This is not a service starved of resources. It is a service strangled by its own bureaucratic mass.

Conservatives have long argued — correctly — that this is an inevitable consequence of monopoly provision. When there is no competition, no patient exit option, and no financial consequence for failure, the institutional incentive is always to expand administration and protect process over outcome. The NHS is not uniquely badly managed. It is predictably badly managed, in precisely the ways economic theory would lead you to expect.

What the Rest of the World Is Doing Differently

The comparison with comparable European nations is instructive and, for NHS loyalists, deeply uncomfortable. France, Germany, the Netherlands, and Sweden all operate universal healthcare systems that guarantee coverage for every citizen — but none of them operate a single-provider state monopoly. All of them incorporate regulated private provision, patient co-payments structured to discourage unnecessary demand, and genuine competition between providers. All of them, by virtually every international metric, outperform the NHS on waiting times, cancer survival rates, and patient satisfaction.

The Commonwealth Fund, hardly a right-wing think tank, has consistently ranked the NHS highly on equity and access whilst ranking it poorly on health outcomes — particularly for serious conditions. The conclusion a rational policymaker ought to draw is clear: the NHS model delivers equality of access to a mediocre standard. That is not good enough for a country of Britain's wealth and ambition.

The strongest argument the left makes in response is that introducing market mechanisms will create a two-tier system in which the wealthy receive better care. This concern is not frivolous — it deserves engagement. But it is empirically undermined by the European experience. Germany has operated a multi-payer insurance system for over a century. The Netherlands reformed its healthcare market comprehensively in 2006. Neither country has descended into the American model that NHS defenders invoke as a bogeyman. Universal coverage and market competition are not mutually exclusive. Britain's refusal to accept this is a political choice, not an economic necessity.

Labour's Ideological Dead End

What makes the current government's position so frustrating is not incompetence — it is ideology masquerading as pragmatism. When Health Secretary Wes Streeting has occasionally suggested that the private sector might have a role to play in clearing backlogs, he has been met with fury from within his own party, from the British Medical Association, and from the trade unions whose institutional interests are bound up in the existing structure. The result is a minister who occasionally says the right things and then retreats under pressure, producing neither genuine reform nor genuine conviction.

The independent sector currently treats around 600,000 NHS-funded patients per year under existing contracts. That number could be expanded significantly with political will. Diagnostic capacity in the private sector remains underutilised. Patient choice — the ability to select a provider and take the funding with you — was partially introduced under Tony Blair and expanded under the coalition government, with measurable improvements in waiting times. Labour has shown little appetite to build on this.

Instead, the government's primary offer is a ten-year workforce plan that will train more doctors and nurses — a welcome development, but one whose benefits will not materialise for a decade, and which does nothing to address the structural incentives that drive inefficiency in the interim.

The Cost of Inaction

Every month that seven and a half million people sit on a waiting list is a month of economic inactivity, of preventable deterioration, of families rearranging their lives around a health system that cannot tell them when it will help them. The productivity cost of long-term sickness and delayed treatment runs into tens of billions of pounds annually, according to estimates from the Health Foundation and the Institute for Public Policy Research.

Britain cannot afford — financially, morally, or politically — to keep treating the NHS as a sacred object immune from structural scrutiny. The service deserves better than the reverence that has protected it from reform. So do patients.

The NHS waiting list is not a natural disaster. It is the predictable consequence of a system designed around political convenience rather than patient outcomes — and until a government finds the courage to say so plainly, the queue will only grow.